Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Cash flow from operating activities
Net Income (Loss)	$ (1,058,729)	$ (83,445)	$ (4,652,493)	$ (3,411,351)	$ (6,060,751)
Adjustment to reconcile comprehensive income/(loss) to net cash used in operating activities
Depreciation and amortization	556,333	562,050	1,649,819	1,685,637
Non-cash expenses			6,117
Provision for Preference dividend			325,127	211,939
Changes in fair value of warrants		(1,857,889)		(1,796,174)
Stock, option, restricted stock unit and warrant expense			49,474	490,175
Foreign exchange translation adjustment			(8,247)	573
Provision for Income taxes ( net of deferred income taxes)			(8,940)	(14,622)
Loss on sale of fixed assets			21,611
Increase (decrease) in:
Accounts receivable			(1,179,303)	(673,381)
Other current assets			(117,845)	(1,388)
Increase (decrease) in:
Accounts payable and accrued expenses			56,085	655,151
Net cash provided by (used in) operating activities			(3,858,595)	(1,474,156)	(2,453,123)
Cash flow from investing activities
Purchase of fixed assets			(46,136)	(27,698)
Acquisition consideration				(200,000)
Net cash used in investing activities			(46,136)	(227,698)
Cash flow from financing activities
Proceeds from bank loan and convertible notes, net			4,588,427	(191,762)
Proceeds from issuance of common shares, net			1,725,000	2,123,425
Net cash provided by financing activities			6,313,427	1,931,663
Net increase (decrease) in cash and cash equivalents			2,408,697	229,809
Cash and cash equivalents as at beginning of the period			431,400	1,371,331	1,371,331
Cash at the end of the period	$ 2,840,097	$ 1,601,140	$ 2,840,097	$ 1,601,140	$ 431,400